SMTI Valuation

Sanara Medtech Inc

Add to Watchlist

Advanced Chart

29.050

+0.200(+0.690%)

Overview
Forecast
Valuation

SMTI Relative Valuation

SMTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SMTI is overvalued; if below, it's undervalued.

Historical Valuation

Sanara Medtech Inc (SMTI) is now in the Fair zone, suggesting that its current forward PS ratio of 2.44 is considered Fairly compared with the five-year average of 4.35. The fair price of Sanara Medtech Inc (SMTI) is between 17.94 to 72.05 according to relative valuation methord.

Relative Value

Fair Zone

17.94-72.05

Current Price：29.05

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

6.45

P/B

Median3y

7.00

Median5y

11.06

-0.09

FCF Yield

Median3y

-1.62

Median5y

-1.89

Competitors Valuation Multiple

The average P/S ratio for SMTI's competitors is 1.33, providing a benchmark for relative valuation. Sanara Medtech Inc Corp (SMTI) exhibits a P/S ratio of 2.44, which is 83.16% above the industry average. Given its robust revenue growth of 48.70%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap